Latest Headlines

1. Sengenics Launches SEROMAX, An At-Home, Antibody Sample Collection Kit That Will Revolutionise Patient Recruitment And Monitoring In Clinical Trials 10/29/2020

   Sengenics, the Functional Proteomics Company, today announced the launch of SEROMAX, a sample collection kit which only requires a pin-prick amount of blood for quantifying antibodies or autoantibodies

2. Optimised Microplate For SARS-CoV-2 Nucleic Acid Purification 10/29/2020

   Porvair Sciences has introduced a new 2.2ml 96 deep well plate specifically designed to be fully compatible with the Thermo Scientific KingFisher range of nucleic acid purification systems

3. Artificial Intelligence Search Technology Will Be Used To Help Modernize US Federal Pathology Facility 10/28/2020

   Technology developed by Canadian researchers has been adopted by a major pathology facility in the United States

4. Eppendorf Introduces Move It® Adjustable Spacing Pipettes 10/28/2020

   Eppendorf AG announces the release of its new Move It® Adjustable Spacing Pipettes. This new line of pipettes significantly reduces operating time when compared to single-channel pipettes, building efficiencies in laboratories

5. Gemelli Biotech Launches Novel Breath Test Measuring Hydrogen, Methane And Hydrogen Sulfide 10/27/2020

   Los Angeles- and Raleigh-based Gemelli Biotech announced the launch of a novel breath test called trio-smart that provides a more complete fermented gas profile of a patient’s microbiome by measuring levels of hydrogen, methane, and hydrogen sulfide after the consumption of a sugar substance (lactulose or glucose)

6. Exact Sciences To Acquire Thrive Earlier Detection, Becoming A Leader In Blood-Based, Multi-Cancer Screening 10/27/2020

   Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. ("Thrive"), a healthcare company dedicated to incorporating earlier cancer detection into routine medical care, today announced they have entered into a definitive agreement under which Exact Sciences will acquire Thrive for cash and stock consideration of up to $2.15 billion

7. EKF Launches PrimeStore MTM Pathogenic Sample Collection And Transportation Kit 10/26/2020

   EKF Diagnostics, the global in vitro diagnostics company, announces that it has launched a PrimeStore MTM sample collection kit. This new kit enables convenient and safe collection, transportation and handling of pathogenic samples, including COVID-19 and influenza.

8. Ortho's VITROS® SARS-CoV-2 Antigen Test Capable Of Accurate Mass-Scale Testing Achieves CE Mark 10/26/2020

   Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU

9. Todos Medical Announces Instrument Validation Complete At MOTO+PARA Mobile Lab 10/26/2020

   Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced the completion of the instrument validation in its mobile lab division

10. Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close To 60 Types Of Cancer 10/26/2020

    Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it has completed over 200,000 cancer detection tests as of September 30, 2020 using its biophysics based cancer screening technology, Cancer Differentiation Analysis (“CDA”)